Journal
VIRULENCE
Volume 11, Issue 1, Pages 88-103Publisher
TAYLOR & FRANCIS INC
DOI: 10.1080/21505594.2019.1708053
Keywords
(5-10); Malaria; Plasmodium falciparum; monocytes; dendritic cells; gamma-delta T cells; NK cells
Categories
Funding
- National Institute of Allergy and Infectious Diseases of the National Institutes of Health [AI110852]
Ask authors/readers for more resources
Individuals growing up in malaria endemic areas gradually develop protection against clinical malaria and passive transfer experiments in humans have demonstrated that this protection is mediated in part by protective antibodies. However, neither the target antigens, specific effector mechanisms, nor the role of continual parasite exposure have been elucidated, which complicates vaccine development. Progress has been made in defining the innate signaling pathways activated by parasite components, including DNA, RNA, hemozoin, and phospholipids, which initiate the immune response and will be the focus of this review. The challenge that remains within the field is to understand the role of these early responses in the development of protective adaptive responses that clear iRBC and block merozoite invasion so that optimal vaccines and therapeutics may be produced.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available